POST FALLS, Idaho, Jan 11, 2000 /PRNewswire via COMTEX/ -- Lifestream
Technologies, Inc. (OTC Bulletin Board: LFST) today announced clearance
by the US Food and Drug Administration of the Company's proprietary
Internet software accessory, Privalink(TM). Privalink is the first
technology that combines a regulated medical device and patient
information through an INTERNET portal using industry-standard Smart
Cards and high-level encryption.
The Privalink(TM) System, developed by Secured Interactive Technologies
which was recently acquired by Lifestream, enables healthcare
professionals to perform a total cholesterol test, add additional
patient health information, perform health risk analysis with the
Lifestream Technologies? Cholesterol Monitor, and then return a
personalized patient evaluation booklet through the INTERNET in less
than 10 minutes.
Christopher Maus, Chairman and Chief Executive Officer, of Lifestream
stated, "Privalink is the worlds first system connecting a regulated
diagnostic device via a Smart Card to an Internet Portal. Our
proprietary cholesterol (lipid) diagnostic system (The Lifestream
Technologies(TM) Cholesterol Monitor), combined with a smart card,
security, the Internet, and database technology, will, for the first
time permit healthcare professionals to provide their patients with
personalized diagnostic, prognostic and authoritative published
recommendations in mere minutes, all with the highest level of security
and privacy."
"This clearance is a major achievement in healthcare for the public.
This proprietary combination of a diagnostic device and our secured
INTERNET site will allow professionals to give patients personalized
recommendations and care that has until now been impossible. With this
final professional clearance, the diagnostic product and operating
system positions the company to move into target markets," stated
Christopher Maus.
"The country and Congress are concerned about the privacy of medical
records and their transmission via the INTERNET. Privalink answers
those concerns," said Ken Clegg Director of Information Technology, for
Lifestream. "Privalink is a proprietary method to ensure that a
patient's personal information is separated from his or her medical
record in the database. Patients carry a 'key' to that record on their
Personal Health Card, which is a personal Smart Card," said Clegg.
"While Smart Cards are reasonably new in the United States,
particularly for medical information, there are projections that there
will be more than 200 million patients carrying these identification
cards in Europe by the end of this year. Through the Privalink System,
Lifestream is positioned to be a leader as this trend hits the
mainstream here in the US."
The Privalink System is unique in its use of encryption and data
splitting to insure absolute patient confidentiality. Company meetings
with Congressional leaders in Washington, DC confirm that the Privalink
System will be compliant with INTERNET and medical information privacy
legislation now under consideration.
The Lifestream Cholesterol Monitor is a hand-held instrument that
identifies total cholesterol from just one drop of blood in
approximately three minutes. Costing the patient less than $10 per
test, the Lifestream Cholesterol Monitor enables healthcare
professionals to easily and inexpensively monitor patients' cholesterol
and their progress on a cholesterol-lowering regimen. The Privalink
system is a subscription-based, closed Internet web site, allowing
healthcare professionals to transmit test results and personal health
data from the instrument and publish a personal recommendation booklet
from scientific literature. Privalink returns a personalized wellness
evaluation to the patient and medical information to the healthcare
professional within minutes.
About Lifestream Technologies, Inc. Lifestream Technologies is a
healthcare company that uniquely links Internet information services to
its medical diagnostic products through encrypted Smart Cards to aid in
the prevention, monitoring and control of disease. The company's first
product is the Lifestream Technologies Cholesterol Monitor; a hand-held
instrument that provides total cholesterol results in three minutes.
Lifestream Technologies received FDA 510(k) clearance to market the
instrument to healthcare professionals in October of 1998, the CDC CLIA
waiver in March of 1999, and a CE mark for Europe.
Communications to the financial community by Lifestream Technologies,
Inc. are not intended nor should they be construed as labeling for the
company's products. Any learned intermediary or healthcare professional
who reads company communications to the financial community should not
rely on these communications for decisions to purchase, indications for
use or instructions to use the Company's products. This news release
may contain information deemed to be forward-looking statements under
the law involving risks and uncertainties. The Company's actual results
could differ materially from this news release. Additional information
about risks of the Company achieving the results suggested by any
forward-looking statements may be found under the heading "Management's
Discussion and Analysis of Financial Condition and Results of
Operations" in the Company's 10-K.
SOURCE Lifestream Technologies, Inc.
(C) 2000 PR Newswire. All rights reserved.
prnewswire.com
-0-
CONTACT: Marie Hirsch of Lifestream Technologies, Inc., 208-457-9409,
ext. 1209
|
